Efracea is a medication primarily used in the treatment of rosacea, a chronic skin condition characterized by facial redness, pimples, swelling, and small and superficial dilated blood vessels. The active ingredient in Efracea is doxycycline, which belongs to a class of medications known as tetracycline antibiotics. However, Efracea is formulated in a low-dose, 40 mg modified-release capsule, which is specifically designed to treat rosacea with a lower risk of antibiotic resistance and fewer side effects compared to higher doses of doxycycline. It works by exerting anti-inflammatory effects and affecting the bacteria associated with rosacea symptoms. Efracea is typically taken once daily and is intended for long-term use to manage the condition effectively.